TIGR is upregulated in the chronic glial scar in response to central nervous system injury and inhibits neurite outgrowth

Molecular and Cellular Neuroscience

Volumn 23, Issue 1, 2003, Pages 69-80

  Jurynec, Michael J ^a,d   Riley, Catherine P ^a   Gupta, Deepak K ^a   Nguyen, Thai D ^b   McKeon, Robert J ^a   Buck, Charles R ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ORIDIS Biomed GmbH   (Austria)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOCILIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BIOASSAY; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GLAUCOMA; GLIA CELL; GROWTH INHIBITION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; MALE; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCAR; UPREGULATION;

MAMMALIA;

EID: 0038173424     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-7431(03)00019-8     Document Type: Article

References (74)

1. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST a new generation of protein database search programs . Nucleic Acids Res. 25:1997;3389-3402.
2. Asher R.A., Morgenstern D.A., Fidler P.S., Adcock K.H., Oohira A., Braistead J.E., Levine J.M., Margolis R.U., Rogers J.H., Fawcett J.W. Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J. Neurosci. 20:2000;2427-2438.
3. Bovolenta P., Fernaud-Espinosa I., Méndez-Otero R., Nieto-Sampedro M. Neurite outgrowth inhibitor of gliotic brain tissue. Mode of action and cellular localization, studied with specific monoclonal antibodies. Eur. J. Neurosci. 9:1997;977-989.
4. Bovolenta P., Wandosell F., Nieto-Sampedro M. Characterization of a neurite outgrowth inhibitor expressed after CNS injury. Eur. J. Neurosci. 5:1993;454-465.
5. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature. 416:2002;636-640.
6. Bregman B.S., Kunkel-Bagden E., Schnell L., Dai H.N., Gao D., Schwab M.E. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature. 378:1995;498-501.
7. Bregman B.S., McAtee M., Dal H.N., Kuhn P.L. Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat. Exp. Neurol. 148:1997;475-494.
8. Buck, C.R., Jurynec, M.J., Gupta, D.K., Law, A.K.T., Bilger, J., Wallace, D.C., McKeon, R.J., 2003. Increased adenine nucleotide translocator 1 in reactive astrocytes facilitates glutamate transport. Exp. Neurol. (in press).
9. Buck C.R., Seburn K.L., Cope T.C. Neurotrophin expression by spinal motoneurons in adult and developing rats. J. Comp. Neurol. 416:2000;309-318.
10. Cajal R.y.S. Degeneration and regeneration of the nervous system. 1929;Hafner, New York.
11. Canning D.R., Höke A., Malemud C.J., Silver J. A potent inhibitor of neurite outgrowth that predominates in the extracellular matrix of reactive astrocytes. Int. J. Dev. Neurosci. 14:1996;153-175.
12. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., Schwab M.E. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 403:2000;434-439.
13. Clark R.K., Lee E.V., Fish C.J., White R.F., Price W.J., Jonak Z.L., Feuerstein G.Z., Barone F.C. Development of tissue damage, inflammation and resolution following stroke an immunohistochemical and quantitative planimetric study . Brain Res. Bull. 31:1993;565-572.
14. Cohen S., Levi-Montalcini R., Hamburger V. A nerve growth-stimulating factor isolated from sarcomas 37 and 180. Proc. Natl. Acad. Sci. USA. 40:1954;1014-1018.
15. Davies S., Fitch M.T., Memberg S.P., Hall A.K., Raisman G., Silver J. Regeneration of adult axons in white matter tracts of the central nervous system. Nature. 390:1997;680-683.
16. Davies S.J., Goucher D.R., Doller C., Silver J. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J. Neurosci. 19:1999;5810-5822.
17. Dergham P., Ellezam B., Essagian C., Avedissian H., Lubell W.D., McKerracher L. Rho signaling pathway targeted to promote spinal cord repair. J. Neurosci. 22:2002;6570-6577.
18. Domeniconi M., Cao Z., Spencer T., Sivasankaran R., Wang K., Nikulina E., Kimura N., Cai H., Deng K., Gao Y., He Z., Filbin M. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron. 35:2002;283-290.
19. Dou C.L., Levine J.M. Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan. J. Neurosci. 14:1994;7616-7628.
20. Dou C.L., Levine J.M. Differential effects of glycosaminoglycans on neurite growth on laminin and L1 substrates. J. Neurosci. 15:1995;8053-8066.
21. Eng L.F., Ghirnikar R.S., Lee Y.L. Glial fibrillary acidic protein GFAP - thirty-one years (1969-2000) . Neurochem. Res. 25:2000;1439-1451.
22. Fautsch M.P., Bahler C.K., Jewison D.J., Johnson D.H. Recombinant TIGR/MYOC increases outflow resistance in the human anterior segment. Invest. Ophthalmol. Vis. Sci. 41:2000;4163-4168.
23. Fawcett J.W., Asher R.A. The glial scar and central nervous system repair. Brain Res. Bull. 49:1999;377-391.
24. Fidler P.S., Schuette K., Asher R.A., Dobbertin A., Thornton S.R., Calle-Patino Y., Muir E., Levine J.M., Geller H.M., Rogers J.H., Faissner A., Fawcett J.W. Comparing astrocytic cell lines that are inhibitory or permissive for axon growth the major axon-inhibitory proteoglycan is NG2 . J. Neurosci. 19:1999;8778-8788.
25. Filla M.S., Liu X., Nguyen T.D., Polansky J.R., Brandt C.R., Kaufman P.L., Peters D.M. In vitro localization of TIGR/MYOC in trabecular meshwork extracellular matrix and binding to fibronectin. Invest. Ophthalmol. Vis. Sci. 43:2002;151-161.
26. Fitch M.T., Silver J. Beyond the glial scar cellular and molecular mechanisms by which glial cells contribute to CNS regenerative failure . Tuszynski M.H., Kordower J.H. CNS Regeneration Basic Science and Clinical Advances . 1999;55-88 Academic Press, New York.
27. Friedlander D.R., Milev P., Karthikeyan L., Margolis R.K., Margolis R.U., Grumet M. The neuronal chondroitin sulfate proteoglycan Neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth. J. Cell Biol. 125:1994;669-680.
28. Gallo V., Chittajallu R. Neuroscience. Unwrapping glial cells from the synapse what lies inside? Science. 292:2001;872-873.
29. GrandPre T., Li S., Strittmatter S.M. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature. 417:2002;547-551.
30. GrandPre T., Nakamura F., Vartanian T., Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature. 403:2000;439-444.
31. Grill R.J., Blesch A., Tuszynski M.H. Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells. Exp. Neurol. 148:1997;444-452.
32. Iozzo R.V. The family of the small leucine-rich proteoglycans key regulators of matrix assembly and cellular growth . Crit. Rev. Biochem. Mol. Biol. 32:1997;141-174.
33. Jaworski D.M., Kelly G.M., Hockfield S. Intracranial injury acutely induces the expression of the secreted isoform of the CNS-specific hyaluronan-binding protein BEHAB/brevican. Exp. Neurol. 157:1999;327-337.
34. Karali A., Russell P., Stefani F.H., Tamm E.R. Localization of myocilin/trabecular meshwork - inducible glucocorticoid response protein in the human eye. Invest. Ophthalmol. Vis. Sci. 41:2000;729-740.
35. Khan S.H., Baziany A., Banigesh A., Hemmings S.J., Shuaib A. Evaluation of an optimal temperature for brain storage in delayed 2,3,5-triphenyltetrazolium chloride staining. J. Neurosci. Methods. 98:2000;43-47.
36. Kim B.S., Savinova O.V., Reedy M.V., Martin J., Lun Y., Gan L., Smith R.S., Tomarev S.I., John S.W.M., Johnson R.L. Targeted disruption of the myocilin gene (Myoc) suggests that human glaucoma-causing mutations are gain of function. Mol. Cell. Biol. 21:2001;7707-7713.
37. Kirstein L., Cvekl A., Chauhan B.K., Tamm E.R. Regulation of human myocilin/TIGR gene transcription in trabecular meshwork cells and astrocytes role of upstream stimulatory factor . Genes Cells. 5:2000;661-676.
38. Kobayashi N.R., Fan D.P., Giehl K.M., Bedard A.M., Wiegand S.J., Tetzlaff W. BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Talpha1-tubulin mRNA expression, and promote axonal regeneration. J. Neurosci. 17:1997;9583-9595.
39. Kubota R., Noda S., Wang Y., Minoshima S., Asakawa S., Kudoh J., Mashima Y., Oguchi Y., Shimizu N. A novel myosin-like protein (myocilin) expressed in the connecting cilium of the photoreceptor molecular cloning, tissue expression, and chromosomal mapping . Genomics. 41:1997;360-369.
40. Levine J.M. Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury. J. Neurosci. 14:1994;4716-4730.
41. Liang P., Pardee A.B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 257:1992;967-971. [comment].
42. Mabuchi F., Yamagata Z., Kashiwagi K., Ishijima K., Tang S., Iijima H., Tsukahara S. A sequence change (Arg158Gln) in the leucine zipper-like motif region of the MYOC/TIGR protein. J. Hum. Genet. 46:2001;85-89.
43. McGraw J., Hiebert G.W., Steeves J.D. Modulating astrogliosis after neurotrauma. J. Neurosci. Res. 63:2001;109-115.
44. McKeon R.J., Höke A., Silver J. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp. Neurol. 136:1995;32-43.
45. McKeon R.J., Jurynec M.J., Buck C.R. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J. Neurosci. 19:1999;10778-10788.
46. McKeon R.J., Schreiber R.C., Rudge J.S., Silver J. Reduction of neurite outgrowth in a model of glial scarring is correlated with the expression of inhibitory molecules on reactive astrocytes. J. Neurosci. 11:1991;3398-3411.
47. McTigue D.M., Wei P., Stokes B.T. Proliferation of ng2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. J. Neurosci. 21:2001;3392-3400.
48. Merkler D., Metz G.A., Raineteau O., Dietz V., Schwab M.E., Fouad K. Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J. Neurosci. 21:2001;3665-3673.
49. Moon L.D., Asher R.A., Rhodes K.E., Fawcett J.W. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat. Neurosci. 4:2001;456-465.
50. Neumann S., Bradke F., Tessier-Lavigne M., Basbaum A.I. Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation. Neuron. 34:2002;885-893.
51. Nguyen T.D., Chen P., Huang W.D., Chen H., Johnson D., Polansky J.R. Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. J. Biol. Chem. 273:1998;6341-6350.
52. Nguyen T.D., Huang W., Bloom E., Polansky J.R. Glucocorticoid (GC) effects on HTM cells molecular biology approaches . Lutjen-Drecoll E. Basic aspects of glaucoma Research III. 3:1993;331-343 Schattauer, Stuttgart/New York.
53. Noda S., Mashima Y., Obazawa M., Kubota R., Oguchi Y., Kudoh J., Minoshima S., Shimizu N. Myocilin expression in the astrocytes of the optic nerve head. Biochem. Biophys. Res. Commun. 276:2000;1129-1135.
54. Ortego J., Escribano J., Coca-Prados M. Cloning and characterization of subtracted cDNAs from a human ciliary body library encoding TIGR, a protein involved in juvenile open angle glaucoma with homology to myosin and olfactomedin. FEBS Lett. 413:1997;349-353.
55. Polansky J.R., Fauss D.J., Chen P., Chen H., Lutjen-Drecoll E., Johnson D., Kurtz R.M., Ma Z.D., Bloom E., Nguyen T.D. Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica. 211:1997;126-139.
56. Polansky J.R., Fauss D.J., Zimmerman C.C. Regulation of TIGR/MYOC gene expression in human trabecular meshwork cells. Eye. 14:2000;503-514.
57. Prinjha R., Moore S.E., Vinson M., Blake S., Morrow R., Christie G., Michalovich D., Simmons D.L., Walsh F.S. Inhibitor of neurite outgrowth in humans. Nature. 403:2000;383-384.
58. Puchala E., Windle W.E. The possibility of structural and functional restitution after spinal cord injury. A review. Exp. Neurol. 55:1977;1-42.
59. Qiu J., Cai D., Dai H., McAtee M., Hoffman P.N., Bregman B.S., Filbin M.T. Spinal axon regeneration induced by elevation of cyclic AMP. Neuron. 34:2002;895-903.
60. Reier P.J., Stensaas L.J., Guth L. The astrocytic scar as an impediment to regeneration in the central nervous system. Kao C., Bunge R., Reier P. Spinal cord reconstruction. 1983;163-195 Raven Press, New York.
61. Retzler C., Göhring W., Rauch U. Analysis of neurocan structures interacting with the neural cell adhesion molecule N-CAM. J. Biol. Chem. 271:1996;27304-27310.
62. Rosenberger C.M., Finlay B.B. Macrophages inhibit Salmonella Typhimurium replication through MEK/ERK kinase and phagocyte NADPH oxidase activities. J. Biol. Chem. 277:2002;18753-18762.
63. Rozsa F.W., Shimizu S., Lichter P.R., Johnson A.T., Othman M.I., Scott K., Downs C.A., Nguyen T.D., Polansky J., Richards J.E. GLC1A mutations point to regions of potential functional importance on the TIGR/MYOC protein. Mol. Vis. 4:1998;20-36.
64. Rudge J.S., Silver J. Inhibition of neurite outgrowth on astroglial scars in vitro. J. Neurosci. 10:1990;3594-3603.
65. Silver I.A., Deas J., Erecinska M. Ion homeostasis in brain cells differences in intracellular ion responses to energy limitation between cultured neurons and glial cells . Neuroscience. 78:1997;589-601.
66. Snow D.M., Lemmon V., Carrino D.A., Caplan A.I., Silver J. Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro. Exp. Neurol. 109:1990;111-130.
67. Stone E.M., Fingert J.H., Alward W.L., Nguyen T.D., Polansky J.R., Sunden S.L., Nishimura D., Clark A.F., Nystuen A., Nichols B.E., Mackey D.A., Ritch R., Kalenak J.W., Craven E.R., Sheffield V.C. Identification of a gene that causes primary open angle glaucoma. Science. 275:1997;668-670.
68. Swiderski R.E., Ross J.L., Fingert J.H., Clark A.F., Alward W.L., Stone E.M., Sheffield V.C. Localization of MYOC transcripts in human eye and optic nerve by in situ hybridization. Invest. Ophthalmol. Vis. Sci. 41:2000;3420-3428.
69. Takahashi H., Noda S., Imamura Y., Nagasawa A., Kubota R., Mashima Y., Kudoh J., Oguchi Y., Shimizu N. Mouse myocilin (Myoc) gene expression in ocular tissues. Biochem. Biophys. Res. Commun. 248:1998;104-109.
70. Valentim L.M., Michalowski C.B., Gottardo S.P., Pedroso L., Gestrich L.G., Netto C.A., Salbego C.G., Rodnight R. Effects of transient cerebral ischemia on glial fibrillary acidic protein phosphorylation and immunocontent in rat hippocampus. Neuroscience. 91:1999;1291-1297.
71. Vannucci S.J., Willing L.B., Goto S., Alkayed N.J., Brucklacher R.M., Wood T.L., Towfighi J., Hurn P.D., Simpson I.A. Experimental stroke in the female diabetic, db/db, mouse. J. Cereb. Blood Flow Metab. 21:2001;52-60.
72. Yamada H., Fredette B., Shitara K., Hagihara K., Miura R., Ranscht B., Stallcup W.B., Yamaguchi Y. The brain chondroitin sulfate proteoglycan brevican associates with astrocytes ensheathing cerebellar glomeruli and inhibits neurite outgrowth from granule neurons. J. Neurosci. 17:1997;7784-7795.
73. Ye J.H., Houle J.D. Treatment of the chronically injured spinal cord with neurotrophic factors can promote axonal regeneration from supraspinal neurons. Exp. Neurol. 143:1997;70-81.
74. Zimmerman C.C., Lingappa V.R., Richards J.E., Rozsa F.W., Lichter P.R., Polansky J.R. A trabecular meshwork glucocorticoid response (TIGR) gene mutation affects translocational processing. Mol. Vis. 5:1999;19-25.